openPR Logo
Press release

Diabetic Macular Edema Market - Key Growth Factors and Forecast 2019

Diabetic Macular Edema Market

Diabetic Macular Edema Market

Macular edema is the condition when the fluid and proteins start collecting on or under the macula of the eye thereby resulting in swelling. Due to such swelling, a person’s central eye vision gets distorted. Macular edema is classified into two types namely cystoids macular edema (CME) and diabetic macular edema (DME).

Obtain Report Details @ http://www.transparencymarketresearch.com/diabetic-macular-edema-market.html

Diabetic macular edema is the major reason for loss of vision in patients suffering from diabetic retinopathy. Diabetes patient are reported to have a 10% risk of developing this condition during their lifetime. On the basis of the cause of disease, DME is classified into two types:

Diffuse macular edema: due to abnormalities in dilated capillaries present in the retina.
Focal macular edema: due to abnormalities in microaneurysms
For diagnosing diabetic macular edema, an ophthalmologist checks the retina for symptoms of the disease including leaking blood vessel, retinal swelling, damaged nerve tissues and pale, fatty deposits on the retina. For further confirmation, comprehensive eye examination such as visual acuity test, dilated exam test and tonometry are performed.

Make an Enquiry @ http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=2248

During the initial stages of DME, no treatment is needed unless the patients efficiently control their blood sugar levels. If the condition becomes severe, the standard treatment for diabetic macular edema is laser photocoagulation. This procedure utilizes laser to reduce edema byapplying a pattern of burnsor bycauterizing leaky blood vessels. For avoiding the side-effects of this treatment, retinal specialists apply injections of anti-vascular endothelial growth factorcorticosteroids along with laser photocoagulation. Currently, there are only two approved drugs available in market for treating DME namely Lucentis and Ozurdex. Other treatment methods are currently under clinical trials.

About Us:-

Transparency Market Research is a market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers.

We are privileged with highly experienced team of Analysts, Researchers and Consultants, who use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Contact Us:-

Transparency Market Research

90 State Street, Suite 700, Albany, NY 12207

Tel: +1-518-618-1030

USA - Canada Toll Free: 866-552-3453

Email: sales@transparencymarketresearch.com

Website: http://www.transparencymarketresearch.com/

Visit Blog: http://marketresearchreports2017.blogspot.in

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Diabetic Macular Edema Market - Key Growth Factors and Forecast 2019 here

News-ID: 718554 • Views: 224

More Releases from Transparency Market Research – Pharmaceutical

Plasma Protease C1-inhibitor Treatment Market Estimated to Flourish by 2025
A fresh market intelligence study by Transparency Market Research (TMR) states that the business landscape of the global plasma protease c1-inhibitor treatment market is consolidated with intense competitive rivalry among leading players. TMR detects Shire plc led the global plasma protease C1-inhibitor treatment market in 2016. Key factors that account for its dominance are expanded product portfolio, acquisitions, and widespread market presence. Pharming Group N.V., CSL Limited, and Sanquin are
Narcolepsy Market - Global Industry Trends and Forecast - 2019
Narcolepsy is a chronic neurological disorder, which is characterized by brain’s inability to control the sleep-wake cycle of an individual. This disorder is not caused due to any mental illness, but is mainly caused due to genetic abnormalities occurring from environmental factors or biologic factors. Narcoleptic individuals exhibita typical characteristic symptom, i.e. excessive daytime sleepiness (EDS), where individuals experience disturbed night sleep and abnormal daytime sleep pattern. Narcolepsy disorder is
Primary Systemic Amyloidosis Market- Get Facts About Business Strategies and Fin …
Amyloids are the substance made up of abnormally formed protein in the bone marrow that gets saturated in different tissues or organs of the body. The condition is termed as amyloidosis. There are various types of amyloidosis out of which primary systemic amyloidosis are most common, these are associated with plasma cell dyscrasia and has no historical evidence of disease. Kidney, intestines, liver, heart and nerves are the common organs
Natamycin Market - Global Industry Analysis 2024
Natamycin is also known commonly as pimaricin or natacyn. It is an anti-fungal agent produced during aerobic fermentation by the Streptomyces natalensis, a bacterium found commonly in soil. Natamycin is a polyene macrolide anti-biotic Natamycin is sparingly soluble in water and required in very low concentrations. available as an odorless, white, granular powder as well as crystalline solid. Commercially, Natamycin can be produced through industrial scale fermentation process with the

All 5 Releases


More Releases for Macular

Macular Edema and Macular Degeneration Market Share, Trends and Analysis, Growth …
Macular edema is a condition in which the retinal layers around the fovea is accumulated by the fluid that leads to the vision impairment and also might lead to the vision loss. Macular edema can be of two types, namely cystoid macular edema and diabetic macular edema. In addition to this, the macular degeneration is a condition in which the loss of vision occurs due to the retinal damage and
Diabetic Macular Edema - Pipeline Review, H2 2017
Market Research Hub (MRH) has recently publicized a new study to its vast repository, which is titled as “Diabetic Macular Edema - Pipeline Review, H2 2017”. Diabetic macular edema (DME) occurs when blood vessels in the retina of patients with diabetes begin to leak into the macula, the part of the eye responsible for detailed central vision. Common symptoms of DME are blurry vision, floaters, double vision, and eventually blindness if
Emerging Opportunities in Wet Macular Degeneration Market
Wet Macular Degeneration Market: Overview Macular degeneration is a weakening or collapsed working of the eyes’ macula. Macula is the small area on the retinal surface covered by the light-sensitive tissue lining which is blackish area of the eye. This part of the retina is responsible for individual’s central vision, allows viewing fine objects clearly. Generally old aged people develop macular degeneration because of natural aging process of the body. There
Global Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market
The Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies. Age related macular degeneration (AMD) is a medical condition that results in loss of vision in the central visual field, owing to damage to the
Diabetic Macular Edema - Pipeline Review, H1 2017
ReportsWorldwide has announced the addition of a new report title Diabetic Macular Edema - Pipeline Review, H1 2017 to its growing collection of premium market research reports. Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Diabetic Macular Edema - Pipeline Review, H1 2017, provides an overview of the Diabetic Macular Edema (Metabolic Disorders) pipeline landscape. Diabetic macular edema (DME) occurs when blood vessels in the retina of patients with diabetes
Growth Macular Edema Therapeutics Market: 2017 - 2025
Macula is oval yellowish area surrounding the center of retina in the eye. Macular edema is the state when fluid and protein start accumulating under macula resulting swelling in the eye. Due to this swelling, central vision of eye get distorted. Macular edema is classified into two types namely cystoids macular edema (CME) and diabetic macular edema (DME). The retina is the light-sensitive tissue at the back of the eye